Lucid Diagnostics (LUCD) News Today → Trump convicted... now what? (From Stansberry Research) (Ad) Free LUCD Stock Alerts $0.74 -0.03 (-4.02%) (As of 12:39 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 8 at 3:38 AM | americanbankingnews.comAscendiant Capital Markets Lowers Lucid Diagnostics (NASDAQ:LUCD) Price Target to $7.50May 20, 2024 | investorplace.comWall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for May 2024May 15, 2024 | markets.businessinsider.comBuy Rating Affirmed for Lucid Diagnostics Amid Positive Financial and Clinical MilestonesMay 15, 2024 | finance.yahoo.comQ1 2024 PAVmed Inc Earnings CallMay 14, 2024 | insidermonkey.comLucid Diagnostics Inc. (NASDAQ:LUCD) Q1 2024 Earnings Call TranscriptMay 14, 2024 | finance.yahoo.comLucid Diagnostics Inc (LUCD) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...May 13, 2024 | prnewswire.comPAVmed Provides Business Update and First Quarter 2024 Financial ResultsMay 13, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Adicet Bio (ACET), Jasper Therapeutics (JSPR) and Lucid Diagnostics (LUCD)May 13, 2024 | investorplace.comLUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q1 2024May 13, 2024 | finance.yahoo.comLucid Diagnostics Provides Business Update and First Quarter 2024 Financial ResultsMay 7, 2024 | prnewswire.comLucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of DirectorsMay 6, 2024 | marketbeat.comLucid Diagnostics (LUCD) Scheduled to Post Earnings on MondayLucid Diagnostics (NASDAQ:LUCD) will be releasing earnings before the market opens on Monday, May 13, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=593600)May 2, 2024 | prnewswire.comLucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer TestingApril 29, 2024 | prnewswire.comLucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness MonthApril 26, 2024 | finance.yahoo.comPAVmed Inc. (PAVM)April 21, 2024 | nasdaq.comLucid Diagnostics Inc. Common Stock (LUCD)April 19, 2024 | investorplace.com3 Penny Stocks That Could Make a Big Comeback by the End of Q2April 15, 2024 | markets.businessinsider.comLucid Diagnostics: Strong Buy Rating with Significant Market Potential Despite Near-Term LossesApril 12, 2024 | markets.businessinsider.comBuy Rating Affirmed for Lucid Diagnostics Amidst Strong EsoGuard Testing Growth and Clear Reimbursement PathApril 10, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Lucid Diagnostics (LUCD), Werewolf Therapeutics (HOWL)April 10, 2024 | investing.comLucid Diagnostics holds Buy rating, and stock target on company's performanceMarch 28, 2024 | seekingalpha.comLucid Diagnostics Inc. (LUCD) Q4 2023 Earnings Call TranscriptMarch 28, 2024 | markets.businessinsider.comBuy Rating for Lucid Diagnostics: Solid Test Volumes and Strategic Growth Initiatives Propel Market PositionMarch 28, 2024 | finance.yahoo.comPAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call TranscriptMarch 28, 2024 | markets.businessinsider.comBuy Rating Affirmed for Lucid Diagnostics Amid Strong Financials and Strategic Growth InitiativesMarch 27, 2024 | finanznachrichten.dePAVmed Inc.: PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial ResultsMarch 27, 2024 | markets.businessinsider.comBuy Rating Affirmed for Lucid Diagnostics Amidst Growing Test Volume and Strategic Positioning for Medicare ReimbursementMarch 27, 2024 | finance.yahoo.comLucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2023 Earnings Call TranscriptMarch 27, 2024 | finance.yahoo.comQ4 2023 Lucid Diagnostics Inc Earnings CallMarch 25, 2024 | investorplace.comLUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q4 2023March 25, 2024 | finance.yahoo.comLucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial ResultsMarch 21, 2024 | markets.businessinsider.comLucid Diagnostics Gets Positive Data From Clinical Validation Study Of EsoGuard Esophageal DNA TestMarch 21, 2024 | prnewswire.comLucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening PopulationMarch 20, 2024 | finance.yahoo.comLucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 ConferenceMarch 11, 2024 | marketbeat.comLucid Diagnostics (LUCD) to Release Earnings on TuesdayLucid Diagnostics (NASDAQ:LUCD) will be releasing earnings on Tuesday, March 12, Yahoo Finance reports.February 21, 2024 | msn.comLucid Diagnostics target oesphageal cancer with early testingFebruary 16, 2024 | prnewswire.comLucid Diagnostics Provides Update Regarding World Trade Center Health ProgramFebruary 16, 2024 | marketbeat.comLucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Up 16.4% in JanuaryLucid Diagnostics Inc. (NASDAQ:LUCD - Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 126,600 shares, an increase of 16.4% from the January 15th total of 108,800 shares. Currently, 1.8% of the company's shares are short sold. Based on an average daily volume of 44,700 shares, the short-interest ratio is presently 2.8 days.February 15, 2024 | finance.yahoo.comLucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional TestimonyFebruary 15, 2024 | prnewswire.comLucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional TestimonyFebruary 8, 2024 | finanznachrichten.deLucid Diagnostics Executes Contract to Provide EsoGuard Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and SurvivorsJanuary 30, 2024 | marketbeat.comLucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest UpdateLucid Diagnostics Inc. (NASDAQ:LUCD - Get Free Report) saw a significant decline in short interest in January. As of January 15th, there was short interest totalling 108,800 shares, a decline of 8.5% from the December 31st total of 118,900 shares. Based on an average daily volume of 40,300 shares, the short-interest ratio is presently 2.7 days. Currently, 1.0% of the shares of the company are short sold.December 30, 2023 | benzinga.comLucid Diagnostics Stock (NASDAQ:LUCD) Dividends: History, Yield and DatesDecember 25, 2023 | finance.yahoo.comThe 3 Most Undervalued Penny Stocks to Buy in DecemberDecember 14, 2023 | za.investing.comNeedham reiterates Buy on Lucid Diagnostics following investor dayDecember 12, 2023 | morningstar.comLucid Diagnostics Inc LUCDDecember 12, 2023 | finance.yahoo.comLucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility StudiesNovember 16, 2023 | finance.yahoo.comLucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2023 Earnings Call TranscriptNovember 14, 2023 | msn.comLucid Diagnostics Non-GAAP EPS of -$0.22 in-line, revenue of $0.8M beats by $0.01MNovember 10, 2023 | benzinga.comEarnings Preview For Lucid Diagnostics Get Lucid Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter. Email Address Nvidia needs this one obscure firm (Ad)In my new investigation, I detail why this is the single most important factor in the future of AI. I explain what this Keystone technology is… why it’s so critical to the future of not just AI but mankind… You must read this new presentation from Porter Stansberry. LUCD Media Mentions By Week LUCD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LUCD News Sentiment▼-0.670.76▲Average Medical News Sentiment LUCD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LUCD Articles This Week▼21▲LUCD Articles Average Week Get Lucid Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TLIS News NH News BDSX News DCTH News PROF News ARAY News CLPT News QIPT News TELA News CVRX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LUCD) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | Sponsored[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...DeFi Distribution | SponsoredTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored